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Diabetes and its complications are major causes of morbidity and mortality in the United States and contribute substantially to health-care costs. Data from the National Health Interview Survey (NHIS) and the Behavioral Risk Factor Surveillance System (BRFSS) have documented steady increases in the prevalence of diabetes (1, 2) . However, these surveys rely only on self-reports of previously diagnosed diabetes and cannot measure the prevalence of undiagnosed diabetes. The change in prevalence demonstrated by these data might reflect other factors such as enhanced detection rather than true increases. The National Health and Nutrition Examination surveys (NHANES) are the only nationally representative surveys that examine both diagnosed and undiagnosed diabetes. During 1976-1980 (NHANES II) and [1988] [1989] [1990] [1991] [1992] [1993] [1994] (NHANES III), the overall combined prevalence of diabetes (diagnosed and undiagnosed on the basis of fasting glucose) increased (3) . This report presents data on prevalence of diagnosed and undiagnosed diabetes and impaired fasting glucose from NHANES 1999-2000 and NHANES III (1988) (1989) (1990) (1991) (1992) (1993) (1994) . The findings indicate that diabetes and impaired fasting glucose continue to affect a major proportion of the U.S. population. An estimated 29 million (14.4%) persons aged >20 years had either diagnosed diabetes, undiagnosed diabetes, or impaired fasting glucose; 29% of diabetes cases were undiagnosed. Persons can reduce their risk for diabetes through weight management and physical activity.
NHANES 1999-2000 (4) was designed to be nationally representative of the U.S. civilian, noninstitutionalized population on the basis of a complex, multistage probability sample. Survey participants were interviewed in their homes and subsequently received physical examinations in mobile examination centers. The household interview was completed by 81.9% of eligible subjects, including 4,880 persons aged >20 years. Persons were asked if, other than during pregnancy for women, a doctor or a health-care professional had ever told them they had diabetes. From these responses, 480 persons aged >20 years were classified as having previously diagnosed diabetes. Of 1,996 persons aged >20 years without diagnosed diabetes who were randomly assigned to a morning examination session and who fasted 9 to <24 hours, plasma glucose values were obtained for 1,734 (87%). Plasma glucose was measured by using a hexokinase enzymatic method with a coefficient of variation of <2.5% during the 2 years of the survey. Diagnostic criteria of the American Diabetes Association (ADA) were used to categorize persons without previously diagnosed diabetes as to whether they had undiagnosed diabetes (fasting plasma glucose >126 mg/dL) or impaired fasting glucose (fasting plasma glucose 110 to <126 mg/dL) (5) .
Findings from NHANES 1999-2000 were compared with those from NHANES III (1988) (1989) (1990) (1991) (1992) (1993) (1994) , which used similar procedures (3) . Sampling weights for the interviewed sample and the morning plasma glucose sample were incorporated to provide estimates that were representative of the U.S. population. Prevalence based on fasting glucose in the morning sample of persons without diagnosed diabetes was adjusted as described previously (6) so estimates based on these data would represent the total U.S. population. Age-and sex-adjusted rates were computed by the direct method by using U.S. 2000 Census data, with age categories of 20-39, 40-59, and >60 years. Replicated variance estimation methods were used to calculate the standard errors, accounting for both the complex sample design and the use of both interview and morning examination sample data in combination. Two sample t-tests were used to test differences in proportions.
The estimated unadjusted prevalence of previously diagnosed diabetes in adults aged >20 years during 1999-2000 was 5.9% (95% confidence interval [CI] = 4.9-6.9) ( Table 1) , representing 11.8 million (95% CI = 9.8-13.8 million) U.S. adults. The prevalence increased by age, reaching 15.0% (95% CI = 12.6-17.5) among persons aged >60 years. Rates were similar by sex. The adjusted prevalence was significantly lower in nonHispanic whites compared with Mexican Americans and nonHispanic blacks. The unadjusted prevalence of undiagnosed diabetes based on fasting glucose in adults aged >20 years was 2.4% (95% CI = 1.5-3.4) during 1999-2000, representing 4.9 million (95% CI = 3.0-6.8 million) U.S. adults. Prevalence increased slightly with age and was similar in men and women. Rates were similar by race/ethnicity.
Combining diagnosed and undiagnosed diabetes (Table 2) , the unadjusted prevalence of total diabetes during 1999-2000 was 8.3% (95% CI = 6.9-9.8), affecting an estimated 16.7 million (95% CI = 13.8-19.6 million) persons aged >20 years. Differences in prevalence by age, sex, and race/ethnicity mirrored those for diagnosed diabetes. During 1999-2000, the proportion of total diabetes that was undiagnosed was 29% (95% CI = 21%-38%). The overall prevalence of diagnosed diabetes, undiagnosed diabetes, total diabetes, and the overall proportion of total diabetes that was undiagnosed did not change significantly from 1988-1994 to 1999-2000 .
Overall prevalence of impaired fasting glucose during 1999-2000 was 6.1% (95% CI = 4.4-7.9) ( Table 1) , representing 12.3 million (95% CI = 8.8-15.8 million) persons aged >20 years. Rates increased with age, were higher in men (7.9%) (95% CI = 5.5-10.2) than in women (4.5%) (95% CI = 2.8-6.2), and were similar by race/ethnicity. The overall decrease in prevalence observed from 1988-1994 to 1999-2000 was not statistically significant.
During 1999-2000, the combined unadjusted prevalence of total diabetes and impaired fasting glucose in adults aged >20 years was 14.4% (95% CI = 12.3%-16.5%) ( Table 2) , representing 29.0 million (95% CI = 24.8-33.2 million) persons. Prevalence increased with age, reaching 33.6% (95% CI = 28.8%-38.4%) by age >60 years. Adjusted prevalence was significantly lower in women than in men, and in Americans had a disproportionately high prevalence compared with non-Hispanic whites. Impaired fasting glucose increases the risk for diabetes and is associated with other cardiovascular risk factors (7) . In 1999-2000, an additional 6.1% of adults had impaired fasting glucose (a rate similar in magnitude to the prevalence of diagnosed diabetes), increasing to 14.4% for persons aged >60 years, with men affected more than women. Overall, an estimated 14.4% of the U.S. population aged >20 years and 33.6% of those aged >60 years had either diabetes or impaired fasting glucose. The findings in this report are subject to at least two limitations. First, the substantially smaller sample size of NHANES 1999-2000 limits the precision of estimated prevalences and the statistical power to detect changes in these estimates between the surveys. Second, because an oral glucose tolerance test (OGTT) was not performed in NHANES 1999-2000, this survey does not capture the additional proportion of persons with abnormal postload glucose tolerance and normal fasting glucose levels. NHANES III (1988) (1989) (1990) (1991) (1992) (1993) (1994) indicated that total glucose intolerance was 36% higher based on OGTT data (3) .
The findings in this report indicate that the prevalence of diabetes, either diagnosed or undiagnosed, and impaired fasting glucose did not appear to increase substantially during the 1990s. Estimates of diagnosed diabetes in NHANES 1999-2000 are similar in magnitude to those from NHIS and BRFSS during the same years. The apparent lack of increase in prevalence is unexpected in light of the increasing prevalence of obesity and overweight in U.S. adults documented by the NHANES surveys (8) . Although a potential change in the ratio of undiagnosed to total diabetes prevalence would be an important finding, the observed differences are not statistically significant. Further investigation with additional years of NHANES data will be necessary to provide more precise estimates. In addition, the potential impact on the prevalence estimates of the change in diagnosis of diabetes adopted by the ADA in 1997 (5) should be accounted for, along with changes in demographic characteristics and overweight.
Recent trials have documented that lifestyle modification (i.e., weight management and increased physical activity) reduces the risk for developing diabetes among persons with impaired glucose tolerance (9) . Other clinical trials and studies have demonstrated that the risk for diabetic complications is reduced substantially by blood glucose, blood pressure, and blood lipid control (10) . These messages should continue to be communicated through education and outreach activities such as the "Steps to a HealthierUS" by the U.S. Department of Health and Human Services (http://www.healthierus.gov/ steps), and the "Small Steps, Big Rewards" (http://ndep.nih. gov/get-info/dpc.htm) and "Control the ABCs of Diabetes" (http://ndep.nih.gov/control/control.htm) campaigns of the National Diabetes Education Program.
During late January 2003, the Michigan Department of Community Health (MDCH) received reports of severe unexplained illnesses and deaths in children and young adults aged <21 years residing in Michigan. Subsequently, two of the deaths were found to be associated with influenza, including one with neurologic complications. To identify cases of severe influenza in otherwise healthy children and young adults aged <21 years, MDCH conducted enhanced surveillance for influenza-associated illness. This report summarizes the findings of this ongoing investigation, which indicate the need to better define the frequency of serious complications from influenza in healthy children and to incorporate such findings into evaluations of current vaccine recommendations for children.
Enhanced surveillance for influenza-associated severe illnesses and deaths focused on children and young adults aged <21 years at low risk* for influenza complications who had illness onset or death after January 1, 2003. Severe influenza-associated illnesses included nonrespiratory complications requiring hospital admission (e.g., myocarditis, rhabdomyolysis, encephalitis, encephalopathy, and prolonged seizures) or any complications requiring intensive care unit * Not a member of a high-risk group (i.e., residents of chronic care facilities; persons with chronic disorders of the circulatory or respiratory system, including asthma; persons with chronic metabolic disorders, renal dysfunction, hemoglobinopathies, or immunosuppression; children on aspirin therapy for chronic conditions; and women who are pregnant (1 (ICU) admission. Influenza infections were confirmed by viral culture, rapid antigen test, immunofluorescence, or immunohistochemical staining (IHC). Surveillance for unexplained deaths also was conducted because of the possibility that such deaths were associated with influenza infection. An unexplained death was defined as a fatal, community-acquired illness in a person aged <21 years with evidence of an infectious process † but for which no specific etiology had been identified. MDCH performed case finding by contacting local health departments, infection-control practitioners, health-care providers, and clinical laboratory directors through the Michigan Health Alert Network, broadcast fax, and e-mail listservs. Medical charts and medical examiner reports were reviewed, health-care providers were interviewed, and clinicians were asked to perform influenza testing on children who were experiencing severe complications from influenza-like illness (ILI). In addition, one Michigan county initiated active emergency department (ED) surveillance in two large tertiary care hospitals by laboratory testing all patients with ILI and evaluating all hospitalized children testing positive for influenza to determine if they had illness consistent with the case definition for influenza-associated severe illness. Available respiratory specimens were obtained and cultured for influenza and other respiratory viruses at local clinical and MDCH laboratories. CDC characterized influenza isolates and evaluated available autopsy specimens by using IHC.
Enhanced surveillance identified 14 influenza cases, comprising four deaths and 10 severe illnesses with onset during January 17-February 21 among children and young adults aged <21 years in Michigan. Of these 14 cases, eight (57%) had evidence of encephalopathy § , including two deaths, and one case had evidence of myocarditis. In addition, four other unexplained deaths are under investigation. This report describes the four influenza-associated deaths and the 10 severe influenza illnesses.
Influenza-Associated Fatality Reports
Case 1. In January, a previously healthy male teenager had onset of fever, nasal congestion, cough, nausea, vomiting, and leg pain. He took over-the-counter (OTC) medications containing pseudoephedrine and acetaminophen that evening and the following morning. On that morning, he was found unresponsive and was transported to an ED, where he could not be resuscitated. ED laboratory tests showed a scan indicated uncal herniation. The patient died 19 hours after admission. Autopsy was declined. A viral culture of the nasopharyngeal specimen obtained during the hospitalization was positive for influenza A virus that was antigenically similar to the vaccine strain influenza A/ New Caledonia/20/99 (H1N1)-like. The patient's illness was consistent with influenza-associated encephalopathy; however, Reye syndrome could not categorically be ruled out because no autopsy was performed. Review of available records revealed no history of influenza vaccination.
Case 4. In February, a boy aged 2 years with a history of resolved reactive airway disease had onset of a fever and cough. The next evening and on the third morning, the patient received a children's formulation of an OTC combination cold medication. After several hours of lethargy, the boy was found unresponsive at home. Paramedics transported the child to the hospital, where attempts to resuscitate were unsuccessful. A postmortem lung swab was positive for influenza A virus by a rapid antigen test, but viral culture was negative. Evaluation of autopsy specimens indicated tracheobronchitis and massive brain edema without evidence of inflammation. IHC of respiratory epithelial cells of trachea and bronchi from centrally located lung tissue was positive for influenza A virus. The patient had not been vaccinated against influenza.
Severe Nonfatal Influenza Illness
Surveillance identified 10 children with severe illnesses that were likely complications of influenza (Table) . The median age of these children was 2.5 years (range: 14 months-9 years); eight patients were female. Nine patients were influenza A virus-positive, and one was influenza B virus-positive. Of the nine influenza A virus cases, eight were confirmed by culture and one by rapid antigen test. Three influenza A virus isolates were H1N1, four were H1N2, and one was H3N2. Of those antigenically characterized, the H1N1 virus isolates and H3N2 markedly elevated white blood cell count (WBC) of 34, 000 cells/mm 3 , (normal range: 4,000-10,500 cells/mm 3 ) with a neutrophilic predominance, a substantially elevated troponin of 98.5 ng/ml (normal range: 0-0.39 ng/ml), and a negative toxicology screen. Evaluation of autopsy specimens indicated interstitial pneumonia and focal myocyte necrosis without frank myocarditis. IHC of respiratory epithelial cells of bronchi from centrally located lung tissue was positive for influenza A virus. Review of available records revealed no history of influenza vaccination.
Case 2. In January, a previously healthy girl aged 6 years with a 1-day history of fever, sore throat, and cough was examined by her primary-care physician and noted to have harsh upper airway sounds. A rapid test of a throat swab for Group A Streptococcus was negative. The patient received oral prednisone for the treatment of croup and an OTC cold medicine containing acetaminophen without salicylates. Later the same day, she complained of leg pain. The next morning, she was found apneic. When paramedics arrived, the patient was in cardiopulmonary arrest and was intubated, resuscitated, and transported to an ED. Her WBC count was 15,900 cells/mm 3 . She was transferred to the pediatric ICU, where she died the same day. A viral culture of an endotracheal aspirate was positive for influenza A virus that was antigenically similar to the vaccine strain A/New Caledonia/20/99 (H1N1)-like. A bacterial culture of a throat swab taken at her primary-care physician's office was positive for Group A Streptococcus. Evaluation of autopsy specimens indicated bronchopneumonia with numerous intracellular bacteria in the intra-alveolar infiltrate. IHC of bronchiolar epithelial cells from lung tissue was positive for influenza A virus but negative for Group A Streptococcus. Review of available records revealed no history of influenza vaccination.
Case 3. In February, a girl aged 5 years with no underlying health conditions had onset of a low-grade fever. During the evening, she became disoriented and lethargic and vomited at least seven times. She had recently completed a course of amoxicillin for treatment of streptococcal pharyngitis. The patient received medications containing ibuprofen; no information about aspirin exposure was available. On arrival to an ED the next day, she had a temperature of 104.1 º F (40.05 º C) and a WBC count of 13,100 cells/mm 3 Editorial Note: Nationally, the 2002-03 influenza season was mild; however, this investigation documented severe influenzaassociated morbidity and mortality, including encephalopathy, among children and young adults aged <21 years in Michigan (1). In Japan, influenza-associated acute encephalopathy among children is a substantial public health problem; in the winter of 1998-99, for example, a total of 148 cases of encephalitis/encephalopathy associated with influenza were reported (2) . Few such cases have been reported in the United States (3, 4) . The reasons for these differences are unclear.
Influenza-associated deaths and severe illnesses in children might be underreported in the United States. Because baseline data on such events are not generally available, whether the cases described in this report represent an increase or are the result of enhanced surveillance is unknown. In addition, because influenza is not a nationally reportable disease, the estimated numbers of annual deaths from influenza are derived from modeling techniques (5) .
Of the four deaths associated with influenza, none were in children considered to be at high risk for influenza, nor were they in the age group for which influenza vaccination is encouraged by the Advisory Committee on Immunization Practices (ACIP) (6) . The risk factors for severe complications and death from influenza in previously healthy children have not been well described. The viruses isolated from these cases were of different types and subtypes and were antigenically similar to viruses in circulation throughout the United States during 2002-03.
Vaccination for influenza is recommended for persons at high risk for complications from influenza. Young, otherwise healthy children aged 6-23 months are at increased risk for influenza-related hospitalization. For this reason, influenza vaccination of healthy children aged 6-23 months is encouraged when feasible (6) . The results of this ongoing investigation indicate the need for further studies to better define the frequency of serious complications from influenza in children and young adults and to incorporate such findings into evaluations of current vaccine recommendations for children.
Self-Reported Concern About Food Security Associated with ObesityWashington, 1995-1999
Obesity is epidemic among all segments of the U.S. population and in all regions of the country, and persons who are obese are at higher risk for several chronic diseases (1). Previous studies have suggested a possible relation between obesity and food insecurity (i.e., not having access at all times to enough safe and nutritious food for an active, healthy lifestyle [2] because such foods are not available consistently or household resources are insufficient to meet the cost) (3) (4) (5) . To assess the relation between obesity and concern about food security, the Washington state Department of Health analyzed statewide data from the 1995-1999 Behavioral Risk Factor Surveillance System (BRFSS). This report summarizes the results of the analysis, which indicate that concern about food security is associated with obesity. Longitudinal studies are needed to determine whether food insecurity causes obesity so appropriate interventions can be designed and implemented.
BRFSS is an ongoing, random-digit-dialed telephone survey of the U.S. civilian, noninstitutionalized population aged >18 years. The state-based survey collects data about modifiable risk factors for chronic diseases and leading causes of death. During 1995-1999, a total of 17,371 persons responded to the Washington BRFSS (median response rate: 52.4%; range: 50.2%-61.5%). The survey collected self-reported data on height and weight that were used to calculate body mass index (BMI) (i.e., weight in kilograms divided by height in meters squared [weight (kg)/height squared (m 2 )]). Obesity was defined as having BMI of >30.0 kg/m 2 . Having concerns about food security was defined as answering "yes" to the question, "In the past 30 days, have you been concerned about having enough food for you or your family?" Each potential risk factor was analyzed separately by using simple logistic regression to identify risk factors for obesity. Multiple logistic regressions were conducted to identify risk factors for obesity while controlling for potential confounders. SUDAAN was used to account for the complex sampling design.
During 1995-1999, of 17,371 respondents, 3,252 (18.7%) were classified as obese. Persons who reported concern about food security, whose annual household income was <$20,000, who had no college education, or who were female, black, American Indian/Alaska Native, Hispanic, or aged >45 years were more likely to be obese than other persons (Table) . Asians/Pacific Islanders were less likely to be obese than whites. Obese persons also were more likely to report a sedentary lifestyle, to eat fewer fruits and vegetables, to have poorer health, and to have received a diagnosis of asthma. Because no significant interactions were found among the independent variables, only the main-effect variables were included in the model. Although reporting poor or fair health status and having received a previous diagnosis of asthma were associated with obesity in the simple logistic regression analyses, these conditions were not included in the multiple regression model because they probably result from rather than cause obesity (6) .
The multiple logistic regression model included income and education as potential confounders. Persons who reported concern about food security were more likely to be obese than those who did not report such concerns (adjusted odds ratio = 1.29; 95% confidence interval = 1.04-1.83 (Table) . Editorial Note: Both obesity and food insecurity are increasing in the United States (1,7). Previously identified risk factors for obesity among adults include having a low income (among women) or education level, being aged >45 years or a member of certain racial/ethnic populations, and not being active physically or eating the recommended amount of fruits and vegetables daily (1) . This report supports the findings of previous studies that food insecurity is associated with obesity (3-5).
Possible explanations for the association between food insecurity and obesity include periods of both under-and overconsumption, physiologic adaptation of increased body fat in response to episodic food shortages, and higher consumption of cheaper foods that are higher in fat (5). For example, diets of food-insecure women include fewer fruits and vegetables (3). Studies of dieters, prisoners of war, and children with food-restrictive parents indicate that food deprivation can lead to overconsumption of foods restricted previously after the restriction ends (5) .
The findings in this report are subject to at least five limitations. First, self-reported data are subject to recall bias and inaccurate reporting of behaviors. Persons who are obese tend to underreport their weight (8) . Second, the data might not be generalizable to the entire population. Third, these data are cross-sectional, which limits the ability to draw conclusions about cause and effect. Fourth, the number of foodinsecure persons might be underestimated because such persons might be less likely to have telephones. Finally, the question used to assess concern about food security has not been tested for reliability or validity. However, patterns of concern about food security and income as determined from one question (9) are consistent with patterns identified from surveys using more questions to determine food security (10) .
Further longitudinal research is needed to determine whether food insecurity causes obesity. If such a relation were to be demonstrated, interventions to reduce food insecurity might reduce the burden of obesity in the United States.
Cigarette Smoking-Attributable Morbidity -United States, 2000
Each year in the United States, approximately 440,000 persons die of a cigarette smoking-attributable illness, resulting in 5.6 million years of potential life lost, $75 billion in direct medical costs, and $82 billion in lost productivity (1). To assess smoking-attributable morbidity, the Roswell Park Cancer Institute, Research Triangle Institute, and CDC analyzed data from three sources: the Behavioral Risk Factor Surveillance System (BRFSS), the National Health and Nutrition Examination Survey III (NHANES III), and the U.S. Census. This report summarizes the results of that analysis, which indicate that an estimated 8.6 million persons in the United States have serious illnesses attributed to smoking; chronic bronchitis and emphysema account for 59% of all smoking-attributable diseases. These findings underscore the need to expand surveillance of the disease burden caused by smoking and to establish comprehensive tobacco-use prevention and cessation efforts to reduce the adverse health impact of smoking.
Data on the number of persons by sex, age group (18-34 years, 35-49 years, 50-64 years, and >65 years), and race (white or other race) for each state and the District of Columbia were obtained from the 2000 U.S. Census. National estimates of the prevalence of current, former, and never smokers* were derived from the combined data from the 1999, 2000, and 2001 BRFSS surveys.
* Current smokers were defined as persons who reported smoking >100 cigarettes during their lifetime and who now smoke some days or every day. Former smokers were defined as persons who reported having smoked >100 cigarettes during their lifetime but did not smoke at the time of interview. Never smokers were defined as persons who reported having smoked <100 cigarettes during their lifetime.
Estimates of the prevalence of smoking-related conditions were obtained from the NHANES III survey for 1988-1994 for current, former, and never smokers for each demographic group to estimate the smoking-attributable fractions of morbid conditions. The smoking-related conditions for which data were collected are those categorized by the U.S. Surgeon General as caused by smoking (2) and addressed in NHANES III. Respondents reported whether a "doctor ever told" them if they had any of the following conditions: stroke, heart attack, emphysema, chronic bronchitis, and specific cancer types, including lung, bladder, mouth/pharynx, esophagus, cervix, kidney, larynx, or pancreas. Smoking-attributable morbidity estimates were obtained in two ways. For one estimate, each person was considered as the unit of analysis, and persons with at least one smoking-related condition were counted as having a condition. For the second estimate, the condition was treated as the unit of analysis, so persons with multiple conditions were counted more than once. Estimates were derived separately for each condition, and the total of all conditions was summed.
The number of persons with a smoking-attributable morbid condition was estimated by state and demographic subpopulations from the following five steps: 1) BRFSS smoking status estimates by demographic group were applied to census data to estimate the number of current, former, and never smokers in each demographic group in each state; 2) NHANES III smoking-related disease frequency data were applied to the numbers from the first step to estimate the number of adults with a smoking-related condition; 3) attributable fractions for current and former smokers in each demographic group were multiplied by the number of persons with a smoking-related disease to yield an estimate of the number of persons with a disease that is attributable to smoking (attributable fraction = [disease prevalence rate exposed -disease prevalence rate unexposed ] / disease prevalence rate exposed ); 4) the numbers obtained from the third step were summed across all demographic categories in each state to yield an estimate of persons with smoking-attributable conditions in each state; and 5) the numbers of smoking-attributable morbid conditions obtained in each state from step four were summed to yield an overall U.S. estimate. Survey designadjusted variance estimates were calculated for each smoking and disease prevalence by using SUDAAN. The variance estimate for the attributable fraction was calculated by using standard methodology (3), and a joint 95% confidence interval (CI) was obtained for each attributable fraction by using Bonferroni's adjustment method (4) .
In 2000, an estimated 8.6 million (95% CI = 6.9-10.5 million) persons in the United States had an estimated 12.7 million (95% CI = 10.8-15.0 million) smoking-attributable conditions. For current smokers, chronic bronchitis was the most prevalent (49%) condition, followed by emphysema (24%). For former smokers, the three most prevalent conditions were chronic bronchitis (26%), emphysema (24%), and previous heart attack (24%). Lung cancer accounted for 1% of all cigarette smoking-attributable illnesses (Table) .
Editorial Note:
This report provides the first national estimates of the number of persons with serious chronic illnesses caused by smoking and the total number of their smokingattributable conditions. The findings indicate that more persons are harmed by tobacco use than is indicated by mortality estimates. Examining trends in tobacco-attributable morbidity provides another way to monitor the progress of tobaccocontrol efforts.
Smoking-attributable mortality estimates published in 2002 (1) differ from the estimates described in this report. Mortality data indicate the number of persons who die of a disease each year, and morbidity data from this study are used to estimate the prevalence of persons living with diseases caused * Cigarette smoking-attributable conditions considered are stroke, heart attack, emphysema, chronic bronchitis, and cancer of the lung, bladder, mouth/pharynx, esophagus, cervix, kidney, larynx, and pancreas. † Current smokers were defined as persons who reported smoking >100 cigarettes during their lifetime and who now smoke some days or every day. Former smokers were defined as persons who reported having smoked >100 cigarettes during their lifetime but did not smoke at the time of interview. § Results are adjusted for age, race, sex, and state/area of residence and rounded to the nearest 1,000. ¶ Numbers might not add to total because of rounding.
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by smoking at a point in time. In addition, mortality estimates are based on official cause of death data and smokingattributable fractions derived from data from the Cancer Prevention Study II, and the smoking-attributable morbidity fractions in this study are based solely on self-reported survey data on diseases addressed in NHANES III. The findings in this report are subject to at least three limitations. First, the estimates do not adjust for potential confounders (e.g., diet, exercise, or geography) other than age, sex, and race/ethnicity. The impact of confounding was examined in a prospective cohort study of approximately one million persons; findings indicated that adjusting for several demographic, behavioral, medical, and occupational factors reduced the smoking attributable mortality estimate by only 2.5%. However, no analyses have been performed that examine smoking-attributable morbidity or that use a broader range of potential confounders (5) . Second, disease data are selfreported and might not represent the true rate or type of disease. A Canadian study found that the rate of underreporting of the chronic conditions cancer, stroke, and hypertension was approximately two times greater than the rate of overreporting (6) . In addition, 63% of NHANES III respondents with documented low-lung function (forced expiratory volume in 1 second was <80% of the predicted value) did not self-report any diagnosis of obstructive lung disease (7) . Therefore, these self-reported data are probably substantial underestimates of a true disease burden. Finally, the scope of diseases considered in this report was limited to those diseases for which survey data were available and those the U.S. Surgeon General implicated smoking as the cause. Various additional chronic and acute conditions affect quality of life and are caused by cigarette smoking. Inclusion of additional diseases would increase the amount of morbidity attributable to smoking.
The findings in this report complement CDC mortality data and estimates of the number of adults with chronic diseases caused by smoking. Approximately 10% of all current and former adult smokers have a smoking-attributable chronic disease. Many of these persons are already experiencing decreased quality of life, and society will likely bear substantial direct and indirect economic costs from these diseases (1). More persons will experience serious chronic diseases attributable to smoking if they continue to smoke (8) . This report underscores the need to expand the implementation of proven strategies to reduce tobacco use such as increasing the cost of cigarettes, increasing clean indoor air regulations, and implementing comprehensive tobacco-use prevention and cessation programs.
Public Health Dispatch

Multistate Outbreak of Hepatitis A Among Young Adult Concert AttendeesUnited States, 2003
In July 2003, a cluster of hepatitis A cases was identified among young adults who had attended outdoor concert and camping events featuring various "jam bands." As of September 2, a total of 25 cases have been reported among residents of nine states (Arizona, California, Colorado, Indiana, Michigan, New York, Oregon, Tennessee, and Wisconsin). The majority of cases were among young adults who attended concerts during the spring and summer. The median age of infected persons was 23 years (range: 17-44 years); 14 (56%) were male.
The bands performing at these concerts and festivals attract fans who travel from one concert to another, sometimes continuously over several months. Concerts often are multiday events involving camping on established or impromptu campgrounds, and sanitary conditions sometimes are poor. Unofficial food vendors are common at these events, and many are concert attendees. Attendance at the events has ranged from 1,200 to 82,000 persons. At large outdoor gatherings, crowded conditions, a lack of hand-washing facilities, and poor sanitation might contribute to the potential for disease transmission (1,2).
Epidemiologic and laboratory investigations are under way to identify potential sources of hepatitis A virus infection and modes of transmission. Several patients have reported close contact with other ill patients during the incubation period, suggesting that person-to-person transmission might play an important role in the spread of the infection. On the basis of early findings in this investigation, vaccination and education campaigns were held at two recent concert events. Approximately 300 attendees were vaccinated, and several contacts were administered postexposure prophylaxis.
The three bands that infected persons most commonly followed completed their summer concert tours in early August. However, fall tours are scheduled to begin in September. Concert attendees are advised to wash their hands frequently with soap and water, particularly after using the bathroom and before eating; to cook their food and drink only potable water; and to avoid food or drugs that could have been prepared under unsanitary conditions or handled by an infected person.
On July 9, the Colorado Department of Public Health and Environment first notified all other states and CDC of a possible cluster of hepatitis A among concert attendees; CDC requested reports of similar cases from other health departments. CDC plans to continue enhanced surveillance for additional cases. Because of the relatively long incubation period for hepatitis A (15-50 days), persons exposed at summer concerts might not become symptomatic until early fall, and transmission could continue with the start of fall tours. CDC requests that young to middle-aged adults with newly diagnosed hepatitis A be asked if they have attended a "jam band" concert or any outdoor concert and associated camping event. Cases of hepatitis A among concert attendees or their infected contacts should be reported to CDC through state or local health departments, and available serum should be saved for molecular testing at CDC. In addition, health departments are encouraged to contact CDC's Division of Viral Hepatitis, telephone 404-371-5419, about cases of hepatitis A that might be related to these concerts. During the reporting week of August 28-September 3, a total of 414 human cases of WNV infection were reported from 22 states (Alabama, Georgia, Iowa, Kansas, Kentucky, Louisiana, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York, Ohio, Oklahoma, Pennsylvania, South Dakota, Tennessee, Texas, Virginia, and Wyoming), including 16 fatal cases from eight states (Iowa, Missouri, Nebraska, New Mexico, New York, South Dakota, Texas, and Wyoming). During the same period, WNV infections were reported in 975 dead birds, 252 horses, one dog, one squirrel, two unidentified animal species, and 532 mosquito pools.
During 2003, a total of 1,856 human cases of WNV infection have been reported from Colorado (n = 635), Nebraska (n = 280), South Dakota (n = 250), Wyoming (n = 164), Texas (n = 146), New Mexico (n = 57), Louisiana (n = 42), Pennsylvania (n = 38), Montana (n = 32), Mississippi (n = 30), North Dakota (n = 28), Alabama (n = 20), Oklahoma (n = 18), Kansas (n = 17), Minnesota (n = 17), Iowa (n = 15), Ohio (n = 14), Missouri (n = six), New York (n = six), Arkansas (n = five), Georgia (n = five), Tennessee (n = five), Florida (n = four), Kentucky (n = four), Virginia (four), New Jersey (n = three), Illinois (n = two), Maryland (n = two), North Carolina (n = two), Arizona (n = one), Connecticut (n = one), Massachusetts (n = one), South Carolina (n = one), and Wisconsin (n = one) (Figure) . Of 1,172 (63%) cases for which demographic data were available, 660 (56%) occurred among males; the median age was 49 years (range: 3 months-97 years), and the dates of illness onset ranged from March 28 to August 27. Of the 1,172 cases, 37 fatal cases were reported from Nebraska (n = eight), Colorado (n = six), New Mexico (n = four), Wyoming (n = four), South Dakota (n = three), Texas (n = three), Alabama (n = two), Iowa (n = two), Kansas (n = one), Mississippi (n = one), Missouri (n = one), New York (n = one), and Ohio (n = one). A total of 157 presumptive WNV viremic blood donors have been reported from Nebraska (n = 73), South Dakota (n = 41), Texas (n = 20), New Mexico (n = seven), Oklahoma (n = four), Iowa (n = three), Mississippi (n = three), Minnesota (n = two), Montana (n = two), Florida (n = one), and Louisiana (n = one). Of these donors, 12 subsequently had WNV fever, and none subsequently had WNV meningoencephalitis. In addition, 5,197 dead birds with WNV infection were reported from 40 states and New York City; 1,162 WNV infections in horses have been reported from 33 states, five WNV infections were reported in dogs, two infections in squirrels, and 12 infections in unidentified animal species. During 2003, WNV seroconversions have been reported in 546 sentinel chicken flocks from 12 states. Louisiana and South Dakota each reported three seropositive sentinel horses. A total of 3,174 WNV-positive mosquito pools have been reported from 32 states and New York City.
Additional information about WNV activity is available from CDC at http://www.cdc.gov/ncidod/dvbid/westnile/ index.htm and http://westnilemaps.usgs.gov.
Notice to Readers
Missing Vials of Aventis Pasteur Rabies Vaccine, August 2003
On August 27, 2003, Aventis Pasteur notified CDC about reports of packages of IMOVAX ® Rabies, Rabies Vaccine (a reconstituted vaccine) that are missing the vial of freezedried vaccine. Each package should contain one diluent syringe and one vaccine vial containing freeze-dried vaccine. An investigation is under way. A communication about this issue will be sent from Aventis Pasteur to customers when additional information becomes available.
Notice to Readers
Satellite Broadcast and Webcast on Managing Rodents and Mosquitoes
CDC will present "Managing Rodents and Mosquitoes through Integrated Pest Management," a live, interactive satellite broadcast and webcast on September 18, 2003, from 1:00-2:30 p.m., EDT. The program will provide information on the need for local health authorities to implement integrated pest management (IPM) as a systems approach in the management of pests and vectors. IPM focuses on the management of the environment in a manner that is effective, safe, economical, and sustained and emphasizes surveillance, community education and outreach, sanitation, and code development and enforcement on a community-wide basis. A question and answer session will enable participants nationwide to ask questions to panelists through toll-free telephone, fax, or TTY lines.
The target audience for this program includes environmental health program directors, managers, and practitioners; directors of health departments and other public health officials; public health nurses; environmental protection practitioners; policy makers; boards of health; academic institutions; national advocacy organizations; and civic leaders. Additional information about program content, registration, continuing education credit, and accessing the live broadcast/webcast is available at http://www.phppo.cdc.gov/phtn/ipm. Information about registration also is available from CDC, telephone 800-418-7246 or 404-639-1292. 
